1. AB0069 TIE2 signalling induces a pro-inflammatory and pro-angiogenic phenotype in differentiated macrophages, independently of macrophage polarization conditions. (23rd January 2014) Authors: García Pérez, S.; Krausz, S.; Ambarus, C.A.; Malvar Fernandez, B.; Baeten, D.L.; Tak, P.P.; Reedquist, K.A. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 641 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0140 Relationship between Expression of Synovial B Cell Survival Factors and Clinical Response to Rituximab Treatment in Rheumatoid Arthritis. (10th June 2014) Authors: Thurlings, R.; Boumans, M.; de Jager, W.; Vos, K.; van Baarsen, L.; Gerlag, D.; Prakken, B.; Tak, P.P. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 850 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0141 The Mucosal Anti-Citrullinated Peptide Antibody Response in Pre-Clinical Rheumatoid Arthritis. (10th June 2014) Authors: Thurlings, R.; van der Horst, A.; Choi, I.; van Schaardenburg, D.; Gerlag, D.; Hamann, D.; Tak, P.P. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 850 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AB0148 Histone deacetylase inhibitors prevent inflammation-mediated inactivation of the forkhead box class o transcription factor FOXO1 in rheumatoid arthritis. (23rd January 2014) Authors: Grabiec, A.M.; Hartkamp, L.M.; van Baarsen, L.G.M.; Korchynskyi, O.; Tak, P.P.; Reedquist, K.A. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 646 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. AB0275 14-3-3 eta is an independent marker of joint damage that complements CRP and anti-CCP. (23rd January 2014) Authors: van der Heijde, D.; Landewé, R.; Allaart, C.F.; Tak, P.P.; Marotta, A.; Maksymowych, W.P. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 653 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. AB0895 Serum biomarkers to predict clinical response in proof-of-concept trials in spondyloarthritis. (23rd January 2014) Authors: Turina, M.; Yeremenko, N.; Paramarta, J.; Vandooren, B.; Tak, P.P.; De Rijcke, L.; Baeten, D. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 690 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. AB0944 Baseline serum 14-3-3 ETA levels predict ACR50 response to adalimumab therapy in psoriatic arthritis. (23rd January 2014) Authors: Marotta, A.; Kuijk, A.W.; Maksymowych, W.P.; Tak, P.P. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 692 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. FRI0006 Class 3 Semaphorins Modulate The Invasive Capacity of Rheumatoid Arthritis Fibroblast-like Synoviocytes. (15th July 2016) Authors: García Pérez, S.; Malvar Fernandez, B.; Tang, M.W.; Newsom, S.P.; Radstake, T.R.; Baeten, D.L.; Tak, P.P.; Reedquist, K.A. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 427 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. FRI0009 CD4+ T helper cells in rheumatoid arthritis express high levels of interleukin-21. (23rd January 2014) Authors: Lebre, M.C.; Vieira, P.L.; Aarrass, S.; Newsom-Davis, T.; Tak, P.P.; Screaton, G.R. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 313 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. FRI0010 Disruption of dominant B-cell/plasma cell clones in rheumatoid arthritis synovium by rituximab correlates with treatment response. (23rd January 2014) Authors: Doorenspleet, M.E.; Klarenbeek, P.L.; Boumans, M.J.; Thurlings, R.M.; Esveldt, R.E.; van Schaik, B.D.; van Kampen, A.H.; Gerlag, D.M.; Baas, F.; Tak, P.P.; Plenge, R.M.; de Vries, N. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 313 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗